Skip to main content
رجوع
ZTS logo

Zoetis Inc.

جودة البيانات: 100%
ZTS
NYSE Healthcare Drug Manufacturers - Specialty & Generic
KWD 113.32
▼ KWD 3.31 (-2.84%)
القيمة السوقية: 49.94B
نطاق اليوم
KWD 113.31 KWD 116.94
نطاق 52 أسبوعًا
KWD 113.31 KWD 172.23
حجم التداول
3,600,162
متوسط 50 يوم / 200 يوم
KWD 124.41 / KWD 138.35
الإغلاق السابق
KWD 116.63

Quick Summary

تاريخ السعر

الاتجاهات المالية

مقارنة الأقران

مقابل وسيط قطاع Healthcare (633 نظير)

المقياس السهم وسيط القطاع
P/E 18.7 0.2
P/B 15.0 2.8
ROE % 66.0 3.7
Net Margin % 28.2 3.9
Rev Growth 5Y % 5.0 10.0
D/E 2.9 0.2

السعر المستهدف للمحللين

Hold
KWD 143.86 +27.0%
Low: KWD 135.00 High: KWD 160.00
مكرر الربحية المستقبلي
16.65
ربحية السهم المستقبلية
KWD 7.01
نمو ربحية السهم (تقدير)
+0.0%
الإيرادات المقدّرة
9.91B

تقديرات الأرباح

الفترة تقدير ربحية السهم تقدير الإيرادات المحللون
FY2030 KWD 9.27
KWD 9.10 – KWD 9.46
11.86B 1
FY2029 KWD 8.69
KWD 8.54 – KWD 8.88
11.35B 1
FY2028 KWD 8.16
KWD 7.75 – KWD 8.40
10.91B 5

Earnings Surprises

Last 8 quarters
Quarter Est. EPS Actual EPS Surprise
2026-02-12 KWD 1.40 KWD 1.48 +5.7%
2025-11-04 KWD 1.62 KWD 1.70 +4.9%
2025-08-05 KWD 1.62 KWD 1.76 +8.6%
2025-05-06 KWD 1.41 KWD 1.48 +5.0%
2025-02-13 KWD 1.37 KWD 1.40 +2.2%
2024-11-04 KWD 1.46 KWD 1.58 +8.2%
2024-08-06 KWD 1.49 KWD 1.56 +4.7%
2024-05-02 KWD 1.34 KWD 1.38 +3.0%

Dividend History

7 yr streak

Yield

0.02%

Payout Ratio

0.33%

Growth (3Y)

15.44%

Growth (5Y)

20.11%

Ex-Date Payment Date Amount Yield
Apr 20, 2026 Jun 02, 2026 KWD 0.53 1.82%
Jan 20, 2026 Mar 03, 2026 KWD 0.53 1.65%
Oct 31, 2025 Dec 02, 2025 KWD 0.50 1.39%
Jul 18, 2025 Sep 03, 2025 KWD 0.50 1.30%
Apr 21, 2025 Jun 03, 2025 KWD 0.50 1.27%
Jan 21, 2025 Mar 04, 2025 KWD 0.50 1.07%
Oct 31, 2024 Dec 03, 2024 KWD 0.43 0.97%
Jul 18, 2024 Sep 04, 2024 KWD 0.43 0.93%
Apr 18, 2024 Jun 04, 2024 KWD 0.43 1.05%
Jan 18, 2024 Mar 01, 2024 KWD 0.43 0.82%
Oct 31, 2023 Dec 01, 2023 KWD 0.38 0.96%
Jul 20, 2023 Sep 01, 2023 KWD 0.38 0.84%
Apr 20, 2023 Jun 01, 2023 KWD 0.38 0.80%
Jan 19, 2023 Mar 01, 2023 KWD 0.38 0.83%
Oct 31, 2022 Dec 01, 2022 KWD 0.33 0.86%
Jul 20, 2022 Sep 01, 2022 KWD 0.33 0.70%
Apr 20, 2022 Jun 01, 2022 KWD 0.33 0.61%
Jan 19, 2022 Mar 01, 2022 KWD 0.33 0.54%
Oct 28, 2021 Dec 01, 2021 KWD 0.25 0.47%
Jul 20, 2021 Sep 01, 2021 KWD 0.25 0.47%

النقاط الرئيسية

Revenue grew 5.04% annually over 5 years — modest growth
ROE of 65.99% indicates high profitability
Net margin of 28.23% shows strong profitability
Debt/Equity of 2.85 — high leverage
Generating 2.28B in free cash flow
Cash machine — converts 85.41% of earnings into free cash flow

النمو

Revenue Growth (5Y)
5.04%
Revenue (1Y)2.28%
Earnings (1Y)7.52%
FCF Growth (3Y)18.68%

الجودة

Return on Equity
65.99%
ROIC21.04%
Net Margin28.23%
Op. Margin38.00%

الأمان

Debt / Equity
2.85
Current Ratio3.03
Interest Coverage14.80

التقييم

P/E Ratio
18.68
Forward P/E16.65
P/B Ratio14.99
EV/EBITDA15.88
Dividend Yield0.02%

All Fundamental Metrics

Growth
Revenue Growth (1Y) 2.28% Revenue Growth (3Y) 5.26%
Earnings Growth (1Y) 7.52% Earnings Growth (3Y) 6.79%
Revenue Growth (5Y) 5.04% Earnings Growth (5Y) 7.03%
Profitability
Revenue (TTM) 9.47B Net Income (TTM) 2.67B
ROE 65.99% ROA 17.28%
Gross Margin 70.49% Operating Margin 38.00%
Net Margin 28.23% Free Cash Flow (TTM) 2.28B
ROIC 21.04% FCF Growth (3Y) 18.68%
Safety
Debt / Equity 2.85 Current Ratio 3.03
Interest Coverage 14.80
Dividends
Dividend Yield 0.02% Payout Ratio 0.33%
Dividend Growth (3Y) 15.44% Dividend Growth (5Y) 20.11%
Consecutive Div Years 7 yrs
Valuation
P/E Ratio 18.68 Forward P/E 16.65
P/B Ratio 14.99 P/S Ratio 5.28
PEG Ratio 2.04 Forward PEG N/A
EV/EBITDA 15.88 Fwd EV/EBITDA 12.75
Forward P/S 5.04 Fwd Earnings Yield 6.01%
FCF Yield 4.57%
Market Cap 49.94B Enterprise Value 57.12B

Income Statement

Annual, most recent first

Income statement data, annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue 9.47B 9.26B 8.54B 8.08B 7.78B
Net Income 2.67B 2.49B 2.34B 2.11B 2.04B
EPS (Diluted) 6.02 5.47 5.07 4.49 4.27
Gross Profit 6.67B 6.40B 5.83B 5.48B 5.31B
Operating Income 3.60B 3.39B 3.07B 2.93B 2.80B

Balance Sheet

Annual, most recent first

Balance sheet data, annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 15.47B 14.24B 14.29B 14.93B 13.90B
Total Liabilities 12.14B 9.47B 9.30B 10.52B 9.36B
Shareholders' Equity 3.33B 4.77B 5.00B 4.41B 4.54B
Total Debt 9.49B 6.74B 6.76B 8.09B 6.74B
Cash & Equivalents 2.31B 1.99B 2.04B 3.58B 3.48B
Current Assets 6.77B 5.99B 6.34B 7.51B 6.93B
Current Liabilities 2.24B 3.41B 1.89B 3.17B 1.80B